Entry Point Capital, LLC Twist Bioscience Corp Transaction History
Entry Point Capital, LLC
- $221 Million
- Q4 2024
A detailed history of Entry Point Capital, LLC transactions in Twist Bioscience Corp stock. As of the latest transaction made, Entry Point Capital, LLC holds 9,040 shares of TWST stock, worth $422,168. This represents 0.19% of its overall portfolio holdings.
Number of Shares
9,040Holding current value
$422,168% of portfolio
0.19%Shares
1 transactions
Others Institutions Holding TWST
# of Institutions
269Shares Held
67.2MCall Options Held
118KPut Options Held
40.2K-
Artisan Partners Limited Partnership Milwaukee, WI5.89MShares$275 Million0.44% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.81MShares$271 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl5.6MShares$261 Million2.28% of portfolio
-
Black Rock Inc. New York, NY5.42MShares$253 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA3.58MShares$167 Million0.03% of portfolio
About Twist Bioscience Corp
- Ticker TWST
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 56,363,500
- Market Cap $2.63B
- Description
- Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...